Eden Research (LON:EDEN) Stock Price Down 3.3% – Time to Sell?

Shares of Eden Research plc (LON:EDEN) were down 3.3% on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The firm has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The firm’s 50 day moving average price is GBX 3.88 and its two-hundred day moving average price is GBX 3.95.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction on Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.